[THE ANTE-NATAL EVALUATION OF FETAL DANGER IN HEMOLYTIC DISEASE].
D000653:Amniotic Fluid; D000906:Antibodies; D000888:Antibodies, Anti-Idiotypic; D001663:Bilirubin; D001769:Blood; D002623:Chemistry Techniques, Analytical; D003298:Coombs Test; D003933:Diagnosis; D004899:Erythroblastosis, Fetal; D005260:Female; D005333:Fetus; D006801:Humans; D007231:Infant, Newborn; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic; D012204:Rh-Hr Blood-Group System; D013057:Spectrum Analysis
D000906:Antibodies; D000888:Antibodies, Anti-Idiotypic; D012204:Rh-Hr Blood-Group System; D001663:Bilirubin
AMNIOTIC FLUID; ANTI-ANTIBODIES; ANTIBODIES; BILIRUBIN; BLOOD; CHEMISTRY, ANALYTICAL; COOMBS' TEST; DIAGNOSIS; ERYTHROBLASTOSIS, FETAL; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; RH FACTORS; SPECTRUM ANALYSIS
DIE ANTENATALE BEURTEILUNG DER FETALEN GEFAEHRDUNG BEI MORBUS HAEMOLYTICUS.